Page last updated: 2024-08-22

trimetazidine and Degenerative Diseases, Central Nervous System

trimetazidine has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Amadio, S; Candelise, N; Coccurello, R; Dobrowolny, G; Ferraro, E; Ferri, A; Giacovazzo, G; Gloriani, M; Lepore, E; Loeffler, JP; Musarò, A; Nesci, V; Ngo, ST; Pieroni, L; Primiano, A; Quessada, C; Renè, F; Salvatori, I; Scaricamazza, S; Steyn, FJ; Tefera, TW; Torcinaro, A; Urbani, A; Valle, C; Volonté, C; Wang, H1

Other Studies

1 other study(ies) available for trimetazidine and Degenerative Diseases, Central Nervous System

ArticleYear
Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1
    British journal of pharmacology, 2022, Volume: 179, Issue:8

    Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Drug Repositioning; Female; Male; Mice; Mice, Transgenic; Neurodegenerative Diseases; Superoxide Dismutase; Superoxide Dismutase-1; Trimetazidine

2022